Synapse - Adult Leukemia

Results (3720)

Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scFv) immune checkpoint blockade

Meeting Abstract

Rafiq, S.; Jackson, H. J.; Yeku, O.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Ahmed, R. N.; Cullen, G. D.; Yan, S.; Wang, P.; more...
Blood (2017)

Fulltext@MSK | Save

Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling

Meeting Abstract

Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
Blood (2017)

Fulltext@MSK | Save

Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia

Meeting Abstract

Quek, L.; David, M.; Kennedy, A.; Metzner, M.; Amatangelo, M.; Shih, A. H.; Stoilova, B.; Karamitros, D.; Quivoron, C.; Heiblig, M.; more...
Blood (2017)

Fulltext@MSK | Save

Enasidenib monotherapy is effective and well-tolerated in patients with previously untreated mutant-IDH2 (m IDH2) acute myeloid leukemia (AML)

Meeting Abstract

Pollyea, D. A.; Tallman, M. S.; De Botton, S.; DiNardo, C. D.; Kantarjian, H. M.; Collins, R. H.; Stein, A. S.; Xu, Q.; Tosolini, A.; Gupta, I.; more...
Blood (2017)

Fulltext@MSK | Save

Activation levels of b-catenin signaling in osteoblasts define a threshold for the development of myeloid neoplasia of variable severity

Meeting Abstract

Mosialou, I.; Cuesta-Dominiguez, A.; Bhagat, G.; Berman, E.; Raza, A.; Kousteni, S.
Blood (2017)

Fulltext@MSK | Save

Targeting cell non-autonomous MAPK activation as a novel therapeutic strategy in myeloproliferative neoplasms

Meeting Abstract

Meyer, S. C.; Ghosh, N.; Stivala, S.; Baerenwaldt, A.; Hao-Shen, H.; Dirnhofer, S.; Dettmer, M. S.; Simillion, C.; Chiu, S.; Keller, M.; more...
Blood (2017)

Fulltext@MSK | Save

SETBP1 and NRAS mutations are frequent events in post-myeloproliferative neoplasm acute myeloid leukemia (post-MPN AML) lacking JAK-STAT activating mutations

Meeting Abstract

Menghrajani, K.; Rapaport, F.; McNamara, C. J.; Devlin, S. M.; Famulare, C.; Patel, M.; Medina, J.; Sandy, L.; Kosiorek, H.; Singer Weinberg, R.; more...
Blood (2017)

Fulltext@MSK | Save

Advanced forms of the myeloproliferative neoplasms are associated with chromosomal abnormalities involving 1q and 12q: Implicating MDM2 and MDM4 in disease progression

Meeting Abstract

Marcellino, B.; Tripodi, J.; Lu, M.; Kosiorek, H.; Mascarenhas, J.; Rampal, R. K.; Dueck, A. C.; Hoffman, R.; Najfeld, V.
Blood (2017)

Fulltext@MSK | Save

Bosutinib in newly diagnosed chronic myeloid leukemia (CML): Gastrointestinal (GI), liver, and hematological safety characterization in the BFORE trial

Meeting Abstract

Mauro, M. J.; Gambacorti-Passerini, C.; Deininger, M. W.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; le Coutre, P. D.; Gutiérrez, V. G.; more...
Blood (2017)

Fulltext@MSK | Save

Combining gene mutation with gene expression data improves outcomes prediction in acute promyelocytic leukemia

Meeting Abstract

Lucena-Araujo, A. R.; Pereira-Martins, D. A.; Koury, L. C. A.; Coelho-Silva, J. L.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; Pasquini, R.; Chiattone, C.; Fagundes, E. M.; more...
Blood (2017)

Fulltext@MSK | Save